These observations point out that NAFLD progresses via the simultaneous suppression of the hepatic program controlled by HNF4α and the activation of the adipogenic program controlled primarily by PPARγ, although to varying degrees. The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatotic liver disease.